You are here

Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update

LONDON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that it will report its audited financial results for the full year ended December 31, 2018 on Tuesday, February 26, 2019.
Wednesday, February 20, 2019 - 02:00